| Primary |
| Type 2 Diabetes Mellitus |
33.1% |
| Glucose Tolerance Impaired |
13.0% |
| Diabetes Mellitus |
12.4% |
| Diabetes Mellitus Non-insulin-dependent |
8.4% |
| Cardiovascular Event Prophylaxis |
7.7% |
| Cerebrovascular Accident Prophylaxis |
6.5% |
| Sarcoma |
4.0% |
| Ischaemic Heart Disease Prophylaxis |
2.5% |
| Product Used For Unknown Indication |
2.5% |
| Prophylaxis |
2.2% |
| Drug Use For Unknown Indication |
1.9% |
| Hypertension |
1.2% |
| Helicobacter Infection |
0.9% |
| Amyotrophic Lateral Sclerosis |
0.6% |
| Blood Glucose Increased |
0.6% |
| Cerebrovascular Accident |
0.6% |
| Gastric Ulcer |
0.6% |
| Non-alcoholic Steatohepatitis |
0.6% |
| Arterial Restenosis |
0.3% |
| Back Pain |
0.3% |
|
| Myocardial Infarction |
10.7% |
| Weight Decreased |
9.3% |
| Weight Increased |
8.0% |
| Cardiac Failure Congestive |
6.7% |
| Oedema |
5.3% |
| Suicide Attempt |
5.3% |
| Death |
4.0% |
| Fall |
4.0% |
| Hypertension |
4.0% |
| Knee Arthroplasty |
4.0% |
| Lumbar Vertebral Fracture |
4.0% |
| Nausea |
4.0% |
| Oedema Peripheral |
4.0% |
| Pain In Extremity |
4.0% |
| Pruritus |
4.0% |
| Troponin Increased |
4.0% |
| Urinary Retention |
4.0% |
| Vomiting |
4.0% |
| Wrist Fracture |
4.0% |
| Bladder Transitional Cell Carcinoma |
2.7% |
|
| Secondary |
| Diabetes Mellitus |
26.3% |
| Type 2 Diabetes Mellitus |
20.8% |
| Drug Use For Unknown Indication |
14.9% |
| Product Used For Unknown Indication |
5.6% |
| Hypertension |
5.0% |
| Hiv Infection |
4.7% |
| Depression |
3.8% |
| Diabetes Mellitus Non-insulin-dependent |
2.3% |
| Multiple Myeloma |
2.3% |
| Hyperlipidaemia |
2.0% |
| Ill-defined Disorder |
1.8% |
| Tachyarrhythmia |
1.8% |
| Cardiovascular Event Prophylaxis |
1.5% |
| Dyslipidaemia |
1.5% |
| Osteoporosis |
1.2% |
| Pain |
1.2% |
| Anxiety |
0.9% |
| Blood Cholesterol |
0.9% |
| Blood Glucose Abnormal |
0.9% |
| Essential Hypertension |
0.9% |
|
| Uveitis |
11.3% |
| Vomiting |
11.3% |
| Completed Suicide |
6.5% |
| Oedema Peripheral |
6.5% |
| Pancreatitis Acute |
6.5% |
| Sinus Bradycardia |
6.5% |
| Glycosylated Haemoglobin Increased |
4.8% |
| Hypoglycaemia |
4.8% |
| Pustular Psoriasis |
4.8% |
| Renal Failure |
4.8% |
| Renal Failure Chronic |
4.8% |
| Diabetes Mellitus Inadequate Control |
3.2% |
| Dyspnoea |
3.2% |
| Femur Fracture |
3.2% |
| Hepatocellular Damage |
3.2% |
| Myocardial Infarction |
3.2% |
| Psychotic Disorder |
3.2% |
| Respiratory Arrest |
3.2% |
| Weight Increased |
3.2% |
| Acute Coronary Syndrome |
1.6% |
|
| Concomitant |
| Drug Use For Unknown Indication |
33.0% |
| Product Used For Unknown Indication |
15.1% |
| Diabetes Mellitus |
11.5% |
| Hypertension |
7.6% |
| Type 2 Diabetes Mellitus |
6.5% |
| Rheumatoid Arthritis |
5.3% |
| Non-small Cell Lung Cancer |
2.5% |
| Hyperlipidaemia |
2.4% |
| Hiv Infection |
2.1% |
| Prophylaxis |
1.8% |
| Diabetes Mellitus Non-insulin-dependent |
1.5% |
| Insomnia |
1.4% |
| Upper Respiratory Tract Inflammation |
1.4% |
| Adverse Event |
1.3% |
| Benign Prostatic Hyperplasia |
1.3% |
| Hypercholesterolaemia |
1.1% |
| Insulin-requiring Type Ii Diabetes Mellitus |
1.1% |
| Pain |
1.1% |
| Asthma |
1.0% |
| Psoriasis |
0.9% |
|
| Pyrexia |
10.6% |
| Renal Failure Acute |
8.1% |
| Nausea |
7.3% |
| Myalgia |
6.5% |
| Thrombocytopenia |
6.5% |
| Weight Decreased |
6.5% |
| Flushing |
4.9% |
| Gastritis |
4.9% |
| Insomnia |
4.9% |
| Granulocytopenia |
4.1% |
| Hypoglycaemia |
4.1% |
| Pneumonia |
4.1% |
| Pruritus |
4.1% |
| Vomiting |
4.1% |
| Hyperglycaemia |
3.3% |
| Initial Insomnia |
3.3% |
| Metabolic Acidosis |
3.3% |
| Middle Insomnia |
3.3% |
| Pleural Effusion |
3.3% |
| Renal Failure |
3.3% |
|
| Interacting |
| Drug Use For Unknown Indication |
27.8% |
| Depression |
22.2% |
| Diabetes Mellitus |
22.2% |
| Tachyarrhythmia |
11.1% |
| Blood Cholesterol Increased |
5.6% |
| Dyslipidaemia |
5.6% |
| High Density Lipoprotein Decreased |
5.6% |
|
| Myocardial Infarction |
60.0% |
| Myoclonus |
40.0% |
|
